Jump to content
RemedySpot.com

Amitriptyline to Relieve Pain in Juvenile Idiopathic Arthritis

Rate this topic


Guest guest

Recommended Posts

Guest guest

Amitriptyline to Relieve Pain in Juvenile Idiopathic Arthritis: A Pilot Study Using Bayesian Metaanalysis of Multiple N-of-1 Clinical Trials

http://www.jrheum.com/abstracts/abstracts07/1125.html ADAM M. HUBER, GEORGE A. TOMLINSON, GIDEON KOREN, and BRIAN M. FELDMAN ABSTRACT.

Objective. Using serial N-of-1 trials and subsequent analysis with Bayesian methods may allow study of therapies using small numbers of subjects. Our research questions were: (1) Can serial N-of-1 trials analyzed with Bayesian statistical techniques be used to estimate the population effect of a therapeutic intervention? (2) Compared to placebo, how likely is it that low-dose amitriptyline therapy in children aged 10–18 years with active polyarticular-course juvenile idiopathic arthritis (JIA) results in a significant improvement in pain? Methods. Six children (age 10.3–16.3 yrs, 4 girls) were enrolled. There were 3 pairs of randomized, double-blinded treatments (amitriptyline 25 mg or placebo) per participant. Each treatment lasted 2 weeks, with a 1 week washout. The primary outcome was pain, measured by 10 cm visual analog scale. Assessments were at the beginning and end of each treatment. A Bayesian statistical model was used to determine the treatment effect. Values < 0 indicated superiority of amitriptyline. Results. Bayesian techniques were used successfully to obtain estimates of population effect, despite the small number of participants. The mean treatment effect for pain was 0.67 (SD 0.89, 95% credible interval –0.99, 2.55). The probability that the treatment effect was < 0 was only 16%. Conclusion. These methods can be used successfully to estimate population effects when sample sizes are small. It is unlikely that amitriptyline reduced pain by a clinically significant amount in these children with polyarticular JIA. These methods may be particularly suited to pilot studies and the study of rare illnesses.

(J Rheumatol 2007;34:1125–32)

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...